ϸ°ûÉúÎïѧ£º (v]%kXy/G
Ò»¡¢ Ãû´Ê½âÊÍ£º mqSVd^
1£® ͬԴºÐ£¨homeobox£©£¨96¡¢99¡¢91£© ",#.?vT`
2£® PCR£¨96£© @Z5q2Q
3£® ·ºËØ£¨ubquitin£©£¨96£© MB]E[&Q!
4£® °é·Ö×Ó£¨chapron£©£¨96£© bWe2z~dP
5£® ת¼Òò×Ó£¨trascription factor£©£¨96£© M8},RR@{
6£® DG£IP3£¨96£© i VSNara
7£® »ùÒòÇóý£*****ene knock out£©£¨96¡¢00£© omG2p
8£® ΢¹Ü×éÖ¯ÖÐÐÄ£¨MTOC£©£¨96¡¢01£© eg[EFI.h
9£® ¶ËÁ£Ã¸£¨telomerase£©£¨96£© yD9enYM
10£® µ°°×·ÖÑ¡£¨protein sorting£©£¨96¡¢99¡¢00£© bt}8ymcG
11£® Transformation£¨92£© 4I4m4^
12£® TransfectionתȾ£¨92£© ghQ B
13£® Transcytosis×ªÒÆ×÷Óã¨92£© (,Y[2_Zv
14£® Transductionתµ¼£¨92£© oW^b,{~V
15£® Transdetermination£¨92£© PGTEIptX7
16£® Transdifferentiation£¨92£© {yn,u)@r9S
17£® Transgenic animalת»ùÒò¶¯Î92£© !I7$e&Uz@
18£® Rb£1£¨92£© dSDZMB sd
19£® P53£¨92¡¢91£© \@Wv{0a(
20£® C£jun£¨92£© zIa={tU
21£® ΢¹Û½áºÏµ°°×MAPS£¨99¡¢91£© Qz(D1>5I?
22£® °ûÄÚÌ壨99£© j0l,1=^>l
23£® Cyclin dependent kinase inhibitor(CDKI)(99) (UkP
AE
24£® G£protein£¨91£© ,np=m17
25£® Restriction point£¨91£© T?3Q<[SmI
26£® Antipost£¨91£© [S6u:;7
27£® Capping£¨91£© "Q: Gd6?h;
28£® TATAbox£¨91£© Q 3WD!Z8y
29£® cDNA library£¨90£© w2B)$u
30£® Aritotic apparatus£¨90£© aCZ0-X?c
31£® ¿çĤÐźŠtransmembrane signal£¨90£© V^7.@BeT
32£® ´ÙÓÐË¿·ÖÁÑÔ mitogen£¨90£© {"o9pIh{~
33£® Nuclear lamina£¨90£© ]d*9@+Iu
34£® ϸ°ûµòÍö£¨apotosis£©£¨00£©
Zkp~qx
35£® ϸ°ûÍâ»ùÖÊ£¨00¡¢01£© W8W7<ml0A
36£® ϸ°û·Ö»¯£¨00£© ()lgd7|+
37£® ϸ°ûÐźÅתµ¼£¨signal transduction£©£¨00£© r S@/@jKZE
38£® ¿Ë¡£¨00£© Z`TfS+O6
39£® »ùÒò×飨00£© MlV(XG>'
40£® Caspase£¨00£© xe@e#9N$
41£® ת¼Òò×Ó£¨00£© lZk
z\
42£® ÅßÌ¥¸Éϸ°û£¨01£© fU6YJs.H^8
43£® ¼¤¹â¹²¾Û½¹ÏÔ΢¾µ£¨01£© p?gm=b#
44£® DNAоƬ£¨01£© ~,lt^@a
¶þ¡¢ ÎÊ´ðÌ⣺
'|H+5#
1£® ÊÔÊöÀÒ°±Ëáµ°°×¼¤Ã¸ÊÜÌåµÄÐźÅͨ·£¨96£© S,5ok0R
2£® ÊÔ¾ÙÀý˵Ã÷ÐÅʹϵͳÖÐÓëϸ°ûÔöÖ³Óйصļ¤Ã¸¼°Æä¹¦ÄÜ£¨95£© x?AG*'
h&
3£® ÊÔ·ÖÎöÐźÅתµ¼£¨transduction£©µÄ¼¸Ìõͨ·µÄ¹²ÐÔÓëÌØÐÔ£¨92£© ~&Z>fgOTJ
4£® µ°°×ÖʵÄÁ×ËữÓëÈ¥Á×ËữÔÚϸ°ûÐźÅϵͳ´«µ¼ÖеÄ×÷Óã¨93¡¢99£© ) .KA0-
5£® ÊÔÊöÁ×õ¥Ë®½âøC£¨PLC£©µÄ·ÖÀ༰ÔÚϸ°ûÐźÅתµ¼ÖеÄ×÷Óᣣ¨01£© $
N?8[
6£® ÊÔÊöϸ°û½ÓÊÜ»¯Ñ§Ðźźóµ÷½Ú»ùÒò±í´ïµÄ;¾¶£¨94£© )+
<w>pc
7£® ÊÔÊöϸ°ûÖÜÆÚ¸÷½×¶ÎÖÐCyclins£CdksµÄµ÷¿Ø×÷Óã¨96£© 5=o ^/Vkc
8£® ¾ÙÀý˵Ã÷CKIÔÚϸ°ûÔöÖ³µ÷¿ØÖеÄ×÷Óã¨96£© (Yewd/T
9£® ÏêÊöcyclins£cdksϵͳÔÚϸ°ûÖÜÆÚG2/M¼°M/G1¹ý¶ÈÖÐÈçºÎÊܵ½µ÷¿ØµÄ£¿ÒÑÖªÄÇЩ·Ö×Ó¿ÉÄÜÊÇcdksµÄµ×Îï¼°ÆäÔÚÁ×ËữÓëÈ¥Á×Ëữ¹ý³ÌÖжÔϸ°û½á¹¹Ó빦Äܱ仯µÄÓ°Ï죨95£© ` GF w?G
10£® Cdc2ºÍcyclin»ùÒò£¨cdc13£©ÈçºÎµ÷¿ØÏ¸°ûÖÜÆÚÔËתµÄÏÖ´ú¸ÅÄ92¡¢94£© ~b_DFj
11£® Ϊʲô˵µ°°×ÖÊÁ×Ëữ£È¥Á×ËữºÍ·ºËؽ鵼µÄµ°°×ÖÊË®½â£¨UPP£©µÄ»¥Ïàе÷ÍÆ¶¯Ï¸°ûÖÜÆÚµÄÔËת£¿£¨01£© 12 p`ZD=
12£® ϸ°ûÔöÖ³µ÷¿ØµÄ·Ö×Ó»úÖÆ£¨00£© t}+/GSwT
13£® ϸ°û¹Ç¼ÜÔÚϸ°ûÔöÖ³ÖÜÆÚÖеÄ×÷Óã¨00£© #-yCR
14£® P34cdc2µÄÐÔÖʼ°Æä×÷Óõ×ÎïÊÇʲô£¿½«ÒýÆðºÎÖÖЧӦ£¿£¨91£© W9SU1{*9
15£® ϸ°ûÓÐË¿·ÖÁÑÖзĴ¸Ìå΢¹ÜµÄ¶¯Á¦Ñ§±ä»¯»úÀí¼°ÆäÓëȾɫÌåÔ˶¯µÄ¹ØÏµ£¨95£© (?e%w}
16£® ΢¹ÜµÄ×é×°ÓëÈ¥×é×°ÔÚϸ°ûÓÐË¿·ÖÁѹý³ÌÖеĶ¯Ì¬±ä»¯¼°Æä×÷Óã¨92£©
53t_#Yte
17£® ϸ°ûÓÐË¿·ÖÁѹý³ÌÖзĴ¸ÌåµÄ×é×°ÓëÈ¥×é×°µÄ¶¯Ì¬±ä»¯¼°Æä¹¦ÄÜ£¨93£© uj.i(Us
18£® ϸ°ûÓÐË¿·ÖÁѺóÆÚȾɫÌå·ÖÀëÇ÷ÏòÁ½¼«µÄ»úÀíÊÇÈçºÎÖ¤Ã÷µÄ£¿£¨90£© =MNp;
19£® ÊÔÊöÖÐÐÄÁ£/¶¯Á£È¥ÔÚϸ°ûÓÐË¿·ÖÁÑÖеÄ×÷Óã¨99£© *OLqr/ yb
20£® KinetochoreÊÇÓÉÄļ¸ÖÖÖ÷Òªµ°°××é³É£¬ÓÃʲô·½·¨Ñо¿Æä¶¨Î»¡¢·Ö×ÓÁ¿¼°»úÄÜ£¿£¨90£© ]-gyXE1.r
21£® ÊÔ·Ö±ðÐðÊöÈËÀà×ÅË¿Á£ºÍ¶¯Á£µÄ»ù±¾×é³É¼«ÆäĿǰËùÖªµÄ¹¦ÄÜ£¨01£© ggDT5hb
22£® ÊÔÊöϸ°û±à³ÌÐÔËÀÍö£¨programmed cell death£©ºÍϸ°ûµòÍö£¨apoptosis£©µÄÌØÕ÷ºÍÉúÀíѧÒâÒå¼°Æä¿ÉÄܵĻùÒòµ÷¿Ø£¬ÄãÈÏΪÑо¿µÄÖØµãÓ¦·ÅÔں䦣¿ÎªÊ²Ã´£¿£¨95£© i{^T;uAE
23£® ApoptosisÓëneerosisµÄ¼ì²âÓëÇø±ð£¨99£© ]dUG=dWO
24£® ÈçºÎ¼ø±ðϸ°ûµòÍöÓ뻵ËÀ¡£Ï¸°ûµòÍöÑо¿µÄÖØÒªÒâÒåÊÇʲô£¿£¨01£© ^xe+(83S2?
25£® ÊÔÊöunipintin£proteasen proteolytic system£¨99£© T;6M UmyC
26£® ÒÑÖªÓÐÄÇЩÖ÷ÒªµÄ°©»ùÒòÓëÒÖ°©»ùÒòÓëϸ°ûÖÜÆÚµÄµ÷¿ØÓйأ¿²¢¾ÙÀý˵Ã÷£¨93£© BqNsW
(+
27£® Oncogene¼°Æä²úÎïÓëϸ°ûÔöÖ³µÄ¹ØÏµ£¨91£© J?O0ixU
28£® ¾ÙÀý˵Ã÷oncogene¡¢growth factors¼°ÊÜÌåÖ®¼äµÄÁªÏµ£¨90£© ~i|6F~%3
29£® ÊÔÊöºáÎÆ¼¡¡¢Ï¸°ûÄÚ´Öϸ˿Á½·Ö×ӵĽṹ¡¢¸÷ÖÖÖ÷Òªµ°°×³É·ÖÔÚ¼¡ÈâÊÕËõÖеÄ×÷Óᣣ¨90£© 01A{\O1$j
30£® ÊÔÊöϸ°ûÖÊÃþÉÏĤµ°°×µÄ¼¸ÖÖÀàÐͼ°Æä¹¦ÄÜ£¨95£© 8w5}9}xF
31£® ÊÔÊöÃâÒßѧ¼¼ÊõÔÚϸ°ûÉúÎïѧÑо¿ÖеÄÓ¦Óã¨92£© ?[JP[
qS
32£® ͬԴºÐµÄ·¢ÏÖ¼°ÆäÔÚÉúÎïÖеÄÖØÒªÒâÒ壨92£© GD4S/fn3
33£® ÈçÒÑ֪ijһ»ùÒòƬ¶ÎÐòÁкÍÒÑ»ñµÃijһµ¥¿Ë¡¿¹ÌåÓ¦ÓúÎÖÖ¼¼Êõ·Ïߵõ½ËüµÄcDNA¿Ë¡£¨94£© o=Vs)8W
34£® ¾ÙÀý˵Ã÷ÃâÒßÓ«¹âFISH¡¢ÃâÒߵ羵ÖîÏî¼¼ÊõµÄ»ù±¾ÔÀí¼°ÆäÔÚϸ°ûÉúÎïѧÑо¿Öеĸ÷½â¾öʲôÎÊÌ⣨94£© TUfj\d,
35£® ÄãµÄ˶ʿÂÛÎÄÌá³öÁËʲôÎÊÌ⣿ÈçºÎ½â¾öµÄ£¿½áÂÛÊÇʲô£¿£¨96¡¢94¡¢00£©